Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case study.
Diana Hull, Ceri Armstrong
Cancer and Genomic Sciences
Research output
:
Contribution to journal
›
Article
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case study.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Advanced Hepatocellular Carcinoma
100%
Sorafenib
100%
Oncology nurses
50%
European Union
25%
Solid Tumors
25%
Chemotherapy Agents
25%
Cancer Types
25%
Current Treatment
25%
Cytotoxic Chemotherapy
25%
Metastatic Renal Cell Carcinoma (mRCC)
25%
Care Coordination
25%
Tyrosine Kinase Inhibitor
25%
Palliative Setting
25%
Targeted Therapy
25%
Multidisciplinary Team Approach
25%
Treatment-related Adverse Events
25%
Coordination Challenges
25%
Carcinoma Renal Cell
25%
Nursing and Health Professions
Liver Cell Carcinoma
100%
Sorafenib
100%
Oncology Nurse
50%
Malignant Neoplasm
25%
Adverse Event
25%
Angiographic Catheter
25%
Solid Malignant Neoplasm
25%
Kidney Metastasis
25%
Protein Tyrosine Kinase Inhibitor
25%
Care Coordination
25%